Stock Quality:
Last 7 days
-24%
Last 30 days
-35.4%
Last 90 days
-50%
Trailing 12 Months
-40.9%
GTBP RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2025 | 0 | 455.0K | 0 | 0 |
2024 | 0 | 0 | 637.0K | 0 |
2023 | 0 | 0 | 0 | 0 |
2022 | 0 | 0 | 0 | 0 |
2021 | 0 | 0 | 0 | 0 |
2016 | 0 | 0 | 0 | 9.8M |
2015 | 0 | 0 | 0 | 0 |
2014 | 0 | 0 | 0 | 0 |
2013 | 666.0K | 990.0K | 1.1M | 875.0K |
2012 | 0 | 131.3K | 236.7K | 342.0K |
2011 | 0 | 16.0K | 21.0K | 26.0K |
2010 | 0 | 0 | 0 | 11.0K |
CEO | Mr. Michael Martin Breen |
---|---|
WEBSITE | gtbiopharma.com |
SECTOR | Healthcare |
INDUSTRY | Biotechnology |
EMPLOYEES | 2 |